As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
The company will review FDA's response and decide on appropriate next steps soon.
The company posted net loss of Rs. 55.51 crores for the period ended December 31, 2019.
The company allocated €56 million to research and development for next-generation line solutions
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
Subscribe To Our Newsletter & Stay Updated
